A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

You may have heard of nasal sprays as a potential treatment option for migraine. But what exactly are they, and how do they work? Below, we’ll answer these questions about migraine nasal sprays ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

One of the most potent methods to soothe these allergy-induced symptoms is the use of an allergy nasal spray. An allergy nasal spray is a medication that is sprayed into the nose to relieve ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

The FDA has approved esketamine (Spravato) nasal spray as a monotherapy for adults with treatment-resistant depression. This ...